Larimar Therapeutics
LRMR
#8809
Rank
A$0.18 B
Marketcap
$2.88
Share price
-6.45%
Change (1 day)
-73.77%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2023 (TTM): -$1.39

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.52. In 2022 the company made an earnings per share (EPS) of -$2.54 an increase over its 2021 EPS that were of -$4.89.

EPS history for Larimar Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.39-45.31%
2022-$2.54-48.15%
2021-$4.89-14.27%
2020-$5.71